Atlas Trials

Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma

Clinical trial NCT05901194 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05901194
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma Non-resectable
Start date
2024-07-10
Primary completion
2027-04-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.